Omada Health
NASDAQ:OMDAMedical - Healthcare Information Services
+$0.13 today
- Market cap
- $817.04M
- Beta
- 2.09
- P/E (TTM)
- -162.6
- EPS (TTM)
- -$0.11
Volume 1.68M
Average 1.07M
OMDA Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Omada HealthNASDAQ: OMDA
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q1 FY2026 depreciation & amortization of $1.51M rose 13.1% year over year, behind the +31.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 4.2% from the prior quarter. Over 3 fiscal years it compounded at +8.2% a year.
Context
- Depreciation & amortization amounted to 2.1% of revenue in FY2025, down 0.7 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +13.1% toward the trailing-twelve-month pace of +31.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 5.49M USD
- Year-over-year change
- +14.3%
- 3-year CAGR
- +8.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.49M | +14.3% |
| FY2024 | 2024-12-31 | 4.8M | +8.0% |
| FY2023 | 2023-12-31 | 4.45M | +2.7% |
| FY2022 | 2022-12-31 | 4.33M | — |
Depreciation & Amortization vs competitors
How OMDA compares with its peers on the latest reported figures
- OMDA's LTM Mar 2026 depreciation & amortization of $6.61M is the 4th largest of the 5 companies compared; the peer median is $71.21M.
- Its year-over-year change of +31.8% is the 2nd highest of 5, against a peer median of +2.4%.
- Depreciation & amortization amounts to 2.3% of revenue for OMDA, versus a peer median of 9.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $370.85M | -0.4% | +10.7% | 14.7% | |
| LTM Sep 2026 | $107.73M | +153.7% | +93.9% | 3.8% | |
| LTM Mar 2026 | $34.69M | +5.2% | +9.1% | 14.6% | |
| LTM Mar 2026 | $6.61M | +31.8% | +8.2% | 2.3% | |
| LTM Jun 2026 | $4.72M | -13.0% | — | 0.7% | |
| Peer median (excluding OMDA) | $71.21M | +2.4% | +10.7% | 9.2% | |
Competitors are the stored peer set for OMDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Net Income | (72.52M) | (67.51M) | (47.14M) | (12.78M) |
| Depreciation & Amortization | 4.33M | 4.45M | 4.8M | 5.49M |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 6.65M | 8.74M | 9.42M | 12.96M |
| Change in Working Capital | (9.15M) | (1.5M) | (6.57M) | 3.74M |
| Accounts Receivables | (3.93M) | (5.34M) | (8.81M) | (12.36M) |
| Inventory | (1.95M) | (74K) | 318K | (1.19M) |
| Accounts Payables | (4.99M) | (286K) | 399K | 6.29M |
| Other Working Capital | 1.73M | 4.2M | 1.52M | 11M |
| Other Non-Cash Items | 1.7M | 6.09M | 5.3M | 8.85M |
| Operating Cash Flow | (68.98M) | (49.74M) | (34.18M) | 18.25M |
| Capital Expenditures | (2.72M) | (2.92M) | (3.86M) | (1.32M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 |
| Other Investing Activities | (2M) | (2.51M) | (3.27M) | (4.51M) |
| Investing Cash Flow | (2.72M) | (2.92M) | (3.86M) | (5.83M) |
| Debt Repayment | (1.27M) | 963K | 0 | (30.96M) |
| Common Stock Issued | 1.74M | 1.76M | 3.33M | 169.9M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.27M | (2.54M) | (4.54M) | (5.71M) |
| Financing Cash Flow | 16.32M | 179K | (1.21M) | 133.22M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | (55.38M) | (52.48M) | (39.25M) | 145.64M |
| Free Cash Flow | (71.7M) | (52.66M) | (38.04M) | 16.93M |
Omada Health
NASDAQ:OMDA
Intrinsic Alpha fair value
Locked
Current Price
$13.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.